NIH-funded research P01 program project

Understanding how genetic variations affect airway disease in primary ciliary dyskinesia.

Official title: Mapping genotype to phenotype in PCD using iPSCs

Funded at Boston University Medical Campus · NIH-11046619 · Data updated 2026-11-12

This study is looking at primary ciliary dyskinesia (PCD) to understand how different genetic changes affect the condition and to find new ways to help treat it, using special cells made from patients' own genes.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$427,602
NIH project number5P01HL170952-02
Project IDNIH-11046619 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with primary ciliary dyskinesia, particularly those with known genetic mutations.

Less likely to help

Patients with other airway diseases or those without a diagnosis of primary ciliary dyskinesia may not benefit from this research.

What this research studies

This research focuses on primary ciliary dyskinesia (PCD), a complex genetic condition that affects the ability of cilia to clear mucus from the airways. By using induced pluripotent stem cells (iPSCs), researchers aim to create airway cells that can mimic the disease's effects. The study will investigate how different genetic mutations contribute to the symptoms of PCD and explore potential pathways for developing targeted therapies. Patients may have their genetic variants analyzed to better understand their specific condition and treatment options.

Why it matters

Potential benefit: If successful, this research could lead to the development of personalized therapies for patients with primary ciliary dyskinesia.

How similar studies have gone: While research on primary ciliary dyskinesia is ongoing, this approach using iPSCs is relatively novel and has not been extensively tested in this context.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Hawkins, Finn — Boston University Medical Campus
  • Study coordinator: Hawkins, Finn

Related research

Other NIH-funded projects on the same topics.

  • Creating a detailed map of early lung cancer changes

    This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.

    NIH research Boston University Medical Campus · Boston, United States · NIH-9627274

  • Telomere trouble in ALT cancers: what causes damage and how it happens

    Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11630744

  • IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV

    This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604270

  • IL-6 signaling and lung injury after TB and HIV co-infection

    This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604269

  • LEAD Africa: advancing Alzheimer’s research across Africa

    A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599552

  • Leading AD and related dementias research in Africa

    A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599551

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.